跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Emeraz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Emeraz
Approved
STANDARD
Emeraz
Lyka Labs Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
488a074e2f3b939d
Company
Lyka Labs Limited
Type
Standard
Approval Details
Approval Id
488a074e2f3b939d
Drug Approval Philippines Name
Emeraz
Product Name
Emeraz
Registration Number
DRP-14924
Brand Name
Emeraz
Generic Name
Esomeprazole (as sodium)
Dosage Form
Lyophilized Powder for I.V. Injection
Dosage Strength
40 mg
Manufacturer
Lyka Labs Limited
Importer
Hexagon Pharmaceuticals
Distributor
Hexagon Pharmaceuticals
Company Detail Path
/organization/lyka-labs-limited
Issuance Date
27 February 2024
Expiry Date
27 February 2029
Pharmacologic Category
Proton pump inhibitor
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
488a074e2f3b939d
Type
Standard
Back to Philippines FDA Approvals